Zobrazeno 1 - 10
of 10
pro vyhledávání: '"Yu V, Chervyakov"'
Publikováno v:
Инновационная медицина Кубани, Vol 0, Iss 2, Pp 5-12 (2023)
Objective: To compare predictive accuracy of the American Society of Anesthesiologists (ASA) score and various cardiac risk indices for perioperative cardiovascular (CV) complications in patients undergoing noncardiac surgery.Materials and methods: W
Externí odkaz:
https://doaj.org/article/dc4f107a03d04c99b6cb9605fee4b2af
Autor:
Yu. V. Chervyakov, I. A. Moskovskiy
Publikováno v:
Амбулаторная хирургия, Vol 19, Iss 1, Pp 51-59 (2022)
Introduction. An alternative way in the treatment of intermittent claudication is the use of genetic engineering technologies that lead to the stimulation of their own vasculogenesis in ischemic limbs. Treatment is carried out on an outpatient basis.
Externí odkaz:
https://doaj.org/article/8c198f81592e449893f3d3668516cc7c
Autor:
Yu. V. Chervyakov, O. N. Vlasenko
Publikováno v:
Вестник хирургии имени И.И. Грекова, Vol 177, Iss 2, Pp 64-69 (2018)
OBJECTIVE. The objective is to compare the effectiveness of standard conservative therapy (SCT) and the complex therapy with preparation based on VEGF165 gene in patients with the stage II of chronic lower limb ischemia according to Fontaine classifi
Externí odkaz:
https://doaj.org/article/33cbf550f3af4f1eaad7d2807fadb0c2
Autor:
Yu V Chervyakov, O N Vlasenko
Publikováno v:
Терапевтический архив, Vol 89, Iss 9, Pp 87-92 (2017)
Aim. To compare the impact of standard conservative treatment (SCT) and its combination with therapeutic angiogenesis for 3 to 5 years on quality of life in patients with Stage II (according to the classification developed by A.V. Pokrovsky-Fontaine)
Externí odkaz:
https://doaj.org/article/a1e400bd449b4e04aec68ee8bed91635
Publikováno v:
Genes & Cells. 17:20-24
The lack of significant progress in improving the results of treatment for patients with chronic lower limb ischemia (CLLI) determines a necessity to search new approaches to solve this problem. One of the promising methods for treatment of patients
Autor:
Yu. V. Chervyakov, I. N. Staroverov, A. V. Borisov, E. G. Nersesyan, O. N. Vlasenko, S. N. Lavlinskiy
Publikováno v:
Вестник хирургии имени И.И. Грекова, Vol 174, Iss 2, Pp 84-88 (2015)
There are several ways of «indirect» revascularization such as revascularizated osteotrepanation of shinbone and lumbar sympathectomy (LS) for treatment of patients with chronic ischemia of lower extremities. They appeared to be sufficiently effect
Externí odkaz:
https://doaj.org/article/6db048e4d9cc4648a7f61019ec720f57
Autor:
Yu. V. Chervyakov, H. N. Ha
Publikováno v:
Патология кровообращения и кардиохирургия, Vol 24, Iss 4, Pp 83-91 (2020)
Aim. To evaluate the effects of complex treatments with no-option chronic limb-threatening ischemia patients with ulcers, using plasmid-based vascular endothelial growth factor-165 (VEGF-165) gene therapy in a one year follow-up period.Methods. In to
Autor:
O N Vlasenko, Yu V Chervyakov
Publikováno v:
Терапевтический архив, Vol 89, Iss 9, Pp 87-92 (2017)
To compare the impact of standard conservative treatment (SCT) and its combination with therapeutic angiogenesis for 3 to 5 years on quality of life in patients with Stage II (according to the classification developed by A.V. Pokrovsky-Fontaine) lowe
Publikováno v:
Angiologiia i sosudistaia khirurgiia = Angiology and vascular surgery. 22(4)
The authors share their experience in comprehensive conservative treatment of patients presenting with chronic lower limb ischaemia (CLLI) associated with atherosclerosis of peripheral arteries by means of the first Russian registered gene therapeuti
Publikováno v:
Angiologiia i sosudistaia khirurgiia = Angiology and vascular surgery. 22(1)
Presented herein are comparative remote results of combined surgical treatment of 121 patients with stage IIB-III lower limb chronic ischaemia (LLCI) by means of indirect revascularization (lumbar sympathectomy--LSE and revascularizing osteotrepanati